Replies to post #35435 on Intellipharmaceutics International Inc. (IPCI)

[doogdilinger]

Agreed mike. I now no longer think that tomorrows s/h of record date pertains to voting on any new BOD additions. But it could have to do with a potential discounted asset sale.

Maybe IPCI sells off their FocalinXR rights to PAR or SeroquelXR rights to MNK or sells off Glucophage to some other entity or sells off their entire generics division at a discounted rate at these currently depressed stock prices to try cure the Nasdaq compliance listing deficiency still in play?

We know that there is value in both Focalin and Seroquel...and could be value in the rest of their generics if placed in the right hands. But if tomorrows vote does pertain to any potential discounted asset(s) sale of that nature...it would certainly explain the need for such a wide gap in the SOR record date and August 15th implementation date right!

[tilator]

interesting guess. That never crossed my mind as I have been thinking about RS/Partnership/spin off....etc. That makes much sense but still why the huge gap betwixt the record date and voting date.

I suppose they just expect price to rise enough in those weeks and nothing is needed when meeting is to come.